The MDS Foundation Needs Your Help! The MDSF will be organizing patient roundtables to better understand the needs of patients with acute myeloid leukemia (AML). The focus of the roundtables will be on the treatment experiences, communications around maintenance therapies and the care available throughout a patient’s journey. We need need patients from France, Germany, and Italy accompanied by their caregivers (where possible).
Please note: Participants do not need to be English-speaking. Interpreters will be provided. Patient briefing and contracting include $150.00 (US Dollars) honorarium per patient per roundtable.
AML Roundtable – Patients from France, Germany, and Italy are needed.
Patient profile criteria:
• received azacytidine (Onureg) following CR or Cri (QUAZAR AML-001),
• or received an alternative maintenance treatment option in an AML setting (Ceplene, Rydapt),
• or treatment naïve AML patients who received venetoclax in combination with azacytidine (Vialea),
• or undergoing induction chemotherapy and are not able to complete intensive curative therapy
If you are an AML patient or know of one who meets the above criteria, please email ahassan@mds-foundation.org.
.
